QDIS Blog

A blog about chemistry, drug development, science, and technology

October 24, 2006

FDA to Review Electronic Signature Regulation

by @ 11:18 am.  Filed under FDA

The Third annual FDA Information Management conference is coming up next month and it will be interesting to see what comes out of it. For a long time 210 CFR Part !! has been controversial and created a lot of confusion and talk concerning implementation and exactly what was required.

FDA to review electronic signature regulation

I remember when these regulation came out and the amount of confusion it caused. Also, many companies were hesitant or refused to go with an electronic system mainly because at the time, none of the commercial software for analytical instruments had the capability to track users and lacked password protection. The main problem was that the regulations were requiring systems that involved many parties and not just the pharmaceutical manufacturers. It wasn’t until the systems software developers were broung into the fol and it explained what was desired and

As the technical person responsible for choosing a contract manufacturer back in the lately 1990’s and early 2000’s, I remember touring contract manufacturers’ analytical labs and one of the first things I always tried was to see if the computers connected to the instruments had password protection. Sadly, many did not and allowed access to the system for anyone who stepped up to them.

The requirements also set up the situation where companies preferred older paper systems and did not investment in modern technology mainly because of fears and misunderstandings of what was required. The result was the law of unintended consequences; the policy for supposedly encouraging adoption of electronic systems actually had the opposite effect.

This is a topic I’ve kept an eye on for years and find fascinating as to how the pendulum has swung in this regard from overly harsh and almost draconian to a more adaptive system. It will be interesting to see what the consensus is after this meeting.

Technorati Tags: , ,

Email Ed Vawter



Related Posts:
  • Follow up on Ranbaxy Offices Being Raided
  • Regulation of Foreign API Manufacturers
  • Medical Errors Hurt 1.5 Million each year
  • IOM review of drug safety system could hurt FDA, industry
  • Spending on Biotech Drugs to Reach 25% by 2012

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    Leave a Reply

    [powered by WordPress.]

    QDIS: blogging about chemistry, drug development, science and technology.

    Internal Links

    Categories

    Search This Blog

    Archives

    October 2006
    S M T W T F S
    « Sep   Nov »
    1234567
    891011121314
    15161718192021
    22232425262728
    293031  

    Search Entire Site

    Subscribe (It's Free!)

    Performancing

    Chemistry, science, and technology for the future.

    logo2

    General Links

    Blog Links

    Chemistry Journal Feeds

    Chemistry Feeds

    35 queries. 1.338 seconds